Biopharma Program To Collaborate on OI
The Drug Discovery and Development website reported that the biopharmaceutical company AstraZeneca and Taiwan’s National Research Program for Biopharmaceuticals have announced a collaborative program to support academic research proposals using open innovation as a catalyst for drug discovery. The program will connect expert physicians and scientists
Comments Off on Biopharma Program To Collaborate on OI • Read this story »